Document is current
Any future updates will be listed below
-
Authors
Patry, Christian https://orcid.org/0000-0002-1270-6508
Webb, Nicholas J. A.
Feißt, Manuel https://orcid.org/0000-0002-5016-9731
Krupka, Kai https://orcid.org/0000-0002-0409-5196
Becker, Jan https://orcid.org/0000-0003-2929-8085
Bald, Martin https://orcid.org/0000-0003-3378-2160
Antoniello, Benedetta https://orcid.org/0009-0002-7011-302X
Bilge, Ilmay https://orcid.org/0000-0002-4852-989X
Gulhan, Bora https://orcid.org/0000-0003-0236-5786
Hogan, Julien
Kanzelmeyer, Nele
Ozkaya, Ozan https://orcid.org/0000-0002-0198-1221
Büscher, Anja
Sellier-Leclerc, Anne-Laure https://orcid.org/0000-0001-9902-0850
Shenoy, Mohan
Weber, Lutz T. https://orcid.org/0000-0003-4116-598X
Fichtner, Alexander https://orcid.org/0000-0002-9939-4059
Höcker, Britta https://orcid.org/0000-0003-4131-2273
Meier, Matthias
Tönshoff, Burkhard https://orcid.org/0000-0002-6598-6910
-
Funding
Funding for this research was provided by:
Novartis Pharma AG
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 30 May 2024
Revised: 2 July 2024
Accepted: 18 July 2024
First Online: 7 August 2024
Declarations
:
: Nicholas JA Webb and Matthias Meier are employees of Novartis, Basel, Switzerland. Burkhard Tönshoff has received research grants from Novartis, Astellas, and Chiesi, and consulting fees from Bristol-Myers Squibb, CSL Behring Biotherapies for Life, Vifor, and Chiesi. Lutz T. Weber has received research grants from Chiesi and lecture fees from Novartis, Alexion, and Chiesi. Jan U. Becker counsels Sanofi. Martin Bald received sponsoring for congress from Novartis and Alexion and speaker fees from Alexion.
